Anthropic Details Claude’s Role in New Drug Development

What happened

Anthropic says it has spent the past few months partnering with six organizations developing new medicines and has begun its own drug discovery efforts. The post says Claude is being used for drug design, experiments and regulatory submission materials, with human clinical trials possible as early as the end of 2028.

Read next

• More changes in today’s briefingIntroducing GPT-6.1 Terra

Reported by 2 sources

The story so far

Anthropic says its scientists have formed research partnerships with six organizations developing new medicines and have also begun their own drug discovery efforts. The partnerships have been underway for the past few months. According to Baoyu’s account of Anthropic’s announcement, Claude is being used for drug design, experiments and preparation of regulatory submission materials. That account says human clinical trials could begin as early as the end of 2028; it presents that timing as a possibility, not a confirmed start date.